Asthma is a chronic inflammatory disease characterized by airway inflammation, mucus hypersecretion and airway hyperresponsiveness. Mechanisms underlying the pathogenesis of asthma are not fully understood. In recent years, there are mounting evidences demonstrating that mammalian chitinases may play a key role in mediating the T-helper 2 cell-driven inflammatory response that is commonly associated with asthma. Chitinases (e.g., chitotriosidase and acidic mammalian chitinase) are enzymes that degrade chitin, the second most abundant biopolymer that can be found in the cell walls of fungi, microfilarial sheaths of helminths, and exoskeletons of insects and crustaceans. There are also chitinase-like proteins (e.g., YKL-40, Ym1 and Ym2) that lack chitinolytic activity but retain chitin-binding ability. Therefore, chitinases were originally believed to function in host defense against parasitic infections, but the first discovery of their role in inflammatory airway diseases came as a surprise. There is ample evidence to support an association of acidic mammalian chitinase and YKL-40 with allergic bronchial asthma in patients. Our recent studies in a mouse asthma model revealed that anti-inflammatory drugs like corticosteroid and cysteinyl leukotriene receptor antagonist were able to suppress elevated pulmonary levels of mammalian chitinases. Taken together, mammalian chitinases may be useful as biomarkers for asthma. Notwithstanding, large-scale multi-center association studies are required to confirm this hypothesis. Besides, substantially more works using knockout mice, recombinant chitinases and siRNA technology are required to investigate a potential role of chitinases in the pathogenesis of asthma.

1.
Beasley R, Crane J, Lai CK, Pearce N: Prevalence and etiology of asthma. J Allergy Clin Immunol 2000;105:S466–S472.
2.
Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–478.
3.
O’Sullivan SM: Asthma death, CD8+ T cells, and viruses. Proc Am Thorac Soc 2005;2:162–165.
4.
Braman SS: The global burden of asthma. Chest 2006;130:4S–12S.
5.
Elias JA, Homer RJ, Hamid Q, Lee CG: Chitinases and chitinase-like proteins in TH2 inflammation and asthma. J Allergy Clin Immunol 2005;116:497–500.
6.
Latge JP: The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 2007;66:279–290.
7.
Dickey BF: Exoskeletons and exhalation. N Engl J Med 2007;357:2082–2084.
8.
Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, Hamid Q, Elias JA: Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004;304:1678–1682.
9.
Funkhouser JD, Aronson NN Jr: Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol Biol 2007;7:96–111.
10.
Bussink AP, Speijer D, Aerts JM, Boot RG: Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics 2007;177:959–970.
11.
Chou YT, Yao S, Czerwinski R, Fleming M, Krykbaev R, Xuan D, Zhou H, Brooks J, Fitz L, Strand J, Presman E, Lin L, Aulabaugh A, Huang X: Kinetic characterization of recombinant human acidic mammalian chitinase. Biochemistry 2006;45:4444–4454.
12.
Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW: Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J Biol Chem 2003;278:37753–37760.
13.
Webb DC, McKenzie AN, Foster PS: Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein. J Biol Chem 2001;276:41969–41976.
14.
Bussink AP, van Eijk M, Renkema GH, Aerts JM, Boot RG: The biology of the Gaucher cell: the cradle of human chitinases. Int Rev Cytol 2006;252:71–128.
15.
Boot RG, Blommart EF, Swart E, Ghauharali-van der Vlugt K, Bijl N, Noe C, Place A, Aerts JM: Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 2001;276:6770–6778.
16.
Boot RG, Bussink AP, Verhoek M, de Boer PA, Moorman AF, Aerts JM: Marked differences in tissue-specific expression of chitinases in mouse and man. J Histochem Cytochem 2005;53:1283–1292.
17.
Choi EH, Zimmerman PA, Foster CB, Zhu S, Kumaraswami V, Nutman TB, Chanock SJ: Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun 2001;2:248–253.
18.
van Eiji M, van Roomen CP, Renkema GH, Bussink AP, Andrews L, Blommaart EF, Sugar A, Verhoeven AJ, Boot RG, Aerts JM: Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 2005;17:1505–1512.
19.
Artieda M, Cenarro A, Ganan A, Jerico I, Gonzalvo C, Casado JM, Vitoria I, Puzo J, Pocovi M, Civeira F: Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003;23:1645–1652.
20.
Malaguarnera L, Di Rosa M, Zambito AM, dell’Ombra N, Niceoletti F, Malaguarnera M: Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut 2008;55:1313–1320.
21.
Brunner JK, Scholl-Bürgi S, Hössinger D, Wondrak P, Prelog M, Zimmerhackl LB: Chitotriosidase activity in juvenile idiopathic arthritis. Rheumatol Int 2008;28:949–950.
22.
Johansen JS: Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodeling, fibroses and cancer. Dan Med Bull 2006;53:172–209.
23.
Kawada M, Hachiya Y, Arihiro A, Mizoguchi E: Role of mammalian chitinases in inflammatory conditions. Keio J Med 2007;56:21–27.
24.
Medoff BD, Thomas SY, Luster AD: T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol 2008;26:205–232.
25.
Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME: Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709–750.
26.
Welch JS, Escoubet-Lozach L, Sykes DB, Liddiard K, Greaves DR, Glass CK: TH2 cytokines and allergic challenge induced Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem 2002;277:42821–42829.
27.
Chang NC, Hung SI, Hwa KY, Kato I, Chen JE, Liu CH, Chang AC: A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem 2001;276:17497–17506.
28.
Malinda KM, Ponce L, Kleinman HK, Shackelton LS, Millis AJ: Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999;250:168–173.
29.
Zimmermann N, Mishra A, King NE, Fulkerson PC, Doepker MP, Nikolaidis NM, Kindinger LE, Moulton EA, Aronow BJ, Rothenberg ME: Transcript signatures in experimental asthma: identification of STAT6-dependent and -independent pathways. J Immunol 2004;172:1815–1824.
30.
Zhao J, Zhu H, Wong CH, Leung KY, Wong WS: Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics 2005;5:2799–2807.
31.
Wong WS, Zhao J: Proteome analysis of chronically inflamed airways in a mouse chronic asthma model. Int Arch Allergy Immunol 2008;147:179–189.
32.
Musumeci M, Bellin M, Maltese A, Aragona P, Bucolo C, Musumeci S: Chitinase levels in the tears of subjects with ocular allergies. Cornea 2008;27:168–173.
33.
Ramanathan M Jr, Lee WK, Lane AP: Increased expression of acidic mammalian chitinase in chronic rhinosinusitis with nasal polyps. Am J Rhinol 2006;20:330–335.
34.
Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, Reed J, Coyle AJ, Kiener P, Cullen M, Grandsaigne M, Dombret MC, Aubier M, Pretolani M, Elias JA: A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007;357:2016–2027.
35.
Kuepper M, Bratke K, Virchow JC: Chitinase-like protein and asthma. N Engl J Med 2008;358:1073–1075.
36.
Zhao J, Yeong LH, Wong WS: Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Int Arch Allergy Immunol 2007;142:219–229.
37.
Wong WSF, Zhu H, Liao W: Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Eur J Pharmacol 2007;575:134–141.
38.
Bao Z, Lim S, Liao W, Lin Y, Thiemermann C, Leung BP, Wong WS: Glycogen synthase kinase-3β inhibition attenuates asthma in mice. Am J Respir Crit Care Med 2007;176:431–438.
39.
Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, Voehringer D, Locksley RM: Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007;447:92–96.
40.
Cartier A, Lehrer SB, Horth-Susin L, Swanson M, Neis B, Howse D, Jong M: Prevalence of crab asthma in crab plant workers in Newfoundland and Labrador. Int J Circumpolar Health 2004;63:333–336.
41.
Bierbaum S, Nickel R, Koch A, Lau S, Deichmann KA, Wahn U, Superti-Furga A, Heinzmann A: Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med 2005;172:1505–1509.
42.
Chatterjee R, Batra J, Das S, Sharma SK, Ghosh B: Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels. J Allergy Clin Immunol 2008;122:202–208.
43.
Bierbaum S, Superti-Furga A, Heinzmann A: Genetic polymorphisms of chitotriosidase in Caucasian children with bronchial asthma. Int J Immunogenet 2006;33:201–204.
44.
Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF Jr, Nicolae DL, Elias JA, Chupp GL: Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008;358:1682–1691.
45.
Moffatt MF, Cookson WO: Asthma and chitinases. N Engl J Med 2008;358:1725–1726.
46.
Vicencio AG, Narain S, Du Z, Zeng WY, Ritch J, Casadevall A, Goldman DL: Pulmonary cryptococcosis induces chitinase in the rat. Respir Res 2008;9:40.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.